Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
Trinity Biotech Welcomes TrinScreen HIV’s Inclusion In The New Kenyan HIV Testing Algorithm
March 22, 2023 11:10 ET
|
Trinity Biotech plc
DUBLIN, Ireland, March 22, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical...
Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2022 Financial Results
March 16, 2023 15:30 ET
|
Trinity Biotech plc
DUBLIN, Ireland, March 16, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech Announces Entry Into An Increased Loan Facility to Fund Potential Acquisitions
February 22, 2023 08:30 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical...
Trinity Biotech Announces Strategic Partnership with imaware™ to Deliver Integrated Diagnostic Testing Solutions to Digital Health Industry
January 09, 2023 08:00 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets,...
Trinity Biotech Announces Q3 2022 Financial Results
December 15, 2022 09:05 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech plc to Announce Third Quarter Fiscal Year 2022 Financial Results
December 09, 2022 05:35 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Dec. 09, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech to participate in the Piper Sandler 34th Annual Healthcare Conference
November 30, 2022 05:50 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
Trinity Biotech Announces Quarter 2 2022 Financial Results And Preliminary Q3 2022 Revenue Guidance
November 03, 2022 09:00 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2022 Financial Results
November 01, 2022 09:15 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech Announces the Appointment of Tom Lindsay to its Board of Directors
October 26, 2022 08:30 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...